e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Aetiology and outcomes of infective exacerbations of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Specific immune response against Haemophilus influenzae in stable COPD
L. Millares, A. Marín, J. García-Aymerich, J. Sauleda, S. Barea, M. García-Nuñez, J. M. Antó, E. Monsó (Badalona, Barcelona, Palma de Mallorca, Spain)
Source:
Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD
Session:
Aetiology and outcomes of infective exacerbations of COPD
Session type:
Oral Presentation
Number:
3846
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Millares, A. Marín, J. García-Aymerich, J. Sauleda, S. Barea, M. García-Nuñez, J. M. Antó, E. Monsó (Badalona, Barcelona, Palma de Mallorca, Spain). Specific immune response against Haemophilus influenzae in stable COPD. Eur Respir J 2010; 36: Suppl. 54, 3846
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Macrophage inflammatory responses to Non-typeable Haemophilus influenzae (NTHi) are strain-dependent
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
Chronic infection by nontypeable
Haemophilus influenzae
fuels airway inflammation
Source: ERJ Open Res, 7 (1) 00614-2020; 10.1183/23120541.00614-2020
Year: 2021
Effect of corticosteroids on innate and adaptive T cell responses to non-typeable Haemophilus influenzae
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017
Host defence functions of BPIFA1 against Non-typeable Haemophilus influenzae
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Infection pattern and inflammatory response in acute and persistent nontypeable
haemophilus influenzae
(NTHi) infection of COPD lung tissue
Source: Eur Respir J 2006; 28: Suppl. 50, 841s
Year: 2006
Monocyte/macrophage killing of nontypeable haemophilus influenzae
Source: Eur Respir J 2006; 28: Suppl. 50, 577s
Year: 2006
Establishment of Nontypeable Haemophilus influenzae airway infection murine model
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
Airway abundance of
Haemophilus influenzae
predicts response to azithromycin in adults with persistent uncontrolled asthma
Source: Eur Respir J, 56 (4) 2000194; 10.1183/13993003.00194-2020
Year: 2020
Clinical impact of a non-typeable Haemophilus influenzae (NTHi) adjuvanted vaccine in adults with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
Alteration of the immune response to nontypeable haemophilus influenzae (NTHI) during COPD exacerbation in mice
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
The persistence of Nontypeable Haemophilus Influenzae fuels type 17 immunity in the lung
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021
Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma
Source: Eur Respir J 2016; 47: 792-800
Year: 2016
Movement of
Haemophilus influenzae
types resistance isolated from sputum in patients with COPD in 2004
Source: Eur Respir J 2005; 26: Suppl. 49, 60s
Year: 2005
Haemophilus influenzae
persists in biofilm communities in a smoke-exposed ferret model of COPD
Source: ERJ Open Res, 6 (3) 00200-2020; 10.1183/23120541.00200-2020
Year: 2020
Primary ciliary dyskinesia exhibits dysregulated epithelial responses to non-typeable Haemophilus influenzae
Source: International Congress 2017 – Paediatric respiratory infections and immunity
Year: 2017
Cellular and cytokine profile following
in vivo
challenge with nontypeable
haemophilus influenzae
in cigarette smoke exposed mice
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) and M. catarrhalis (Mcat) adjuvanted vaccines in adults
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
In vitro
infection with nontypeable
Haemophilus influenzae
in a model of human lung tissues and cells
Source: Eur Respir J 2005; 26: Suppl. 49, 405s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept